Examples of using T-cell in English and their translations into Vietnamese
{-}
-
Colloquial
-
Ecclesiastic
-
Computer
needed] Thus pimecrolimus inhibits T-cell activation by inhibiting the synthesis and release of cytokines from T-cells.
in a process known as adoptive T-cell immunotherapy- an approach that has been very successful so far,
Furthermore, when blood samples from patients were analysed, Balachandran et al. found that, compared with short-term survivors, the long-term survivors had a higher frequency of neoantigens generated from mutations in the gene MUC16 and had T-cell responses against mutant MUC16.
where it interferes with lymphocyte activation.[2] It is also being studied in the treatment of cutaneous T-cell lymphoma and T-cell non-Hodgkin lymphoma.[3].
Editas Medicine's research to address blindness, and the University of Pennsylvania's tumor-targeting T-cell research- the first trial of CRISPR in humans in the U.S.
for the treatment of chronic hepatitis B. It is also used in the treatment of certain T-cell lymphomas, particularly mycosis fungoides.
Tremelimumab blocks the binding of the antigen-presenting cell ligands B7.1 and B7.2 to CTLA-4, resulting in inhibition of B7-CTLA-4-mediated downregulation of T-cell activation; subsequently, B7.1 or B7.2 may interact with another T-cell surface receptor protein, CD28, resulting in a B7-CD28-mediated T-cell activation unopposed by B7-CTLA-4-mediated inhibition.
They test for T-cell lymphoma?
Allison was studying the T-cell protein CTLA-4.
When CAR T-cell works, it really works.
Your T-Cell count's improving. Better.
Your T-cell count is down to nine.
Allison studied the T-cell protein CTLA-4.…….
Right now, your T-cell count is 14.
Different MHC antigens are recognized by different T-cell types.
Symptoms vary according to the specific type of T-cell lymphoma.
Signs and symptoms vary according to the specific subtype of T-cell lymphoma.
There is an inverse relationship between the T-cell collection and MHC diversity.
The treatment is known in the medical community as CAR T-cell therapy.
It achieves this by enhancing T-cell proliferation in response to the infection.